Upload your raw 23andMe, AncestryDNA, or WGS file to map your likely gut, barrier, and immune-reactivity drivers for free.
Gut problems are not always just about what you eat.
For many people, the deeper issue is not a single “bad food” or missing probiotic. It may involve how the body moves food through the gut, digests carbohydrates, produces and recycles bile, protects the intestinal surface, and regulates immune tolerance.
That is why two people can both experience bloating, constipation, diarrhea, food reactions, or digestive sensitivity while having very different biological drivers.
Mutant helps you move from generic gut-health advice to driver-matched genetic pattern analysis.
If you experience bloating, constipation, delayed reactions, gas, loose stools, poor fat tolerance, food sensitivity, changing tolerance, or inflammatory digestive flares, the next question is not only:
Which food is causing this?
The better question may be:
Which gut-health driver is creating the most pressure?
Mutant uses your raw DNA file and symptom context to help map five connected gut-health pathways:
Gut reactivity can develop through different combinations of slow clearance, incomplete digestion, bile instability, weaker surface defense, and heightened immune response.
Mutant does not treat gut health as one single microbiome problem.
It separates your pattern into five possible driver lanes:
Each lane points toward a different interpretation.
One person may have food and waste moving through the digestive tract too slowly. Another may have difficulty breaking down particular carbohydrates before they reach the colon. Another may have less stable bile production or recycling. Another may have weaker intestinal surface defenses. Another may have an immune system that reacts strongly and takes longer to return to baseline.
These patterns may overlap, but they are not interchangeable.
Food, waste, and microbial byproducts may move through the digestive tract more slowly or less consistently than expected.
Gut motility is the coordinated movement that carries food through the stomach and intestines and eventually clears waste from the colon.
This process depends on the enteric nervous system, smooth-muscle signaling, autonomic regulation, electrolyte balance, thyroid signaling, and communication between the brain and digestive tract.
When clearance is slower, the issue may not appear immediately after a meal. Symptoms can accumulate as food, gas, stool, and fermentation pressure remain in the digestive tract longer.
BDNF, SLC35F3, XPR1, TRPM8, COLQ
Gene coverage varies by DNA file. Mutant uses converging patterns rather than treating any one gene as proof of impaired motility.
Thyroid signaling helps regulate metabolic pace and gastrointestinal movement.
When cellular thyroid effect is weaker, slower transit may increase constipation, fermentation, food-trigger variability, and the time required to return to baseline after a reaction.
If your digestive symptoms overlap with coldness, low energy, brain fog, weakness, or thyroid-like symptoms despite normal TSH, read the free thyroid DNA analysis.
The autonomic nervous system helps regulate digestion.
For some people, stress does not only create an uncomfortable sensation in the stomach. It may change motility, meal tolerance, bowel rhythm, and the coordination required for digestion and clearance.
This is primarily a movement and clearance problem, not simply a food-selection problem.
Removing more foods may temporarily reduce pressure, but it does not necessarily explain why the gut is clearing slowly.
Certain sugars and starches may be broken down less completely before reaching the colon.
Carbohydrates normally need to be broken into smaller molecules before they can be absorbed.
When a particular carbohydrate is not fully digested or absorbed in the small intestine, more of it can reach the colon. Gut bacteria can then ferment it, producing gas and drawing additional fluid into the bowel.
This is one reason carbohydrate reactions may depend heavily on dose, timing, food combinations, intestinal health, and which carbohydrate was consumed.
SI, LCT, MCM6
These genes may provide information about specific digestive tendencies, but symptoms can also be influenced by intestinal injury, infections, inflammation, microbiome activity, medication use, and transit time.
Fermentation happens through microbial activity, but the pressure may begin upstream.
If the small intestine does not fully digest or absorb a carbohydrate, even a normal colonic microbial community receives more material to ferment.
The question is therefore not always:
Which bacteria should I eliminate?
It may be:
Why is so much fermentable material reaching the bacteria in the first place?
Slower movement gives digestive contents and fermentation products more time to accumulate.
That means a moderate carbohydrate-digestion weakness may feel much worse when constipation or delayed clearance is also present.
This is an upstream digestion and downstream fermentation problem.
The food may be the immediate trigger, but the amount reaching the colon may be the deeper issue.
Bile production, composition, transport, or recycling may be less stable.
Bile helps the body digest and absorb fats. Bile acids are also recycled between the intestine and liver through a tightly regulated transport system.
When this system is under pressure, symptoms may appear after fatty meals, during periods of stress, after rapid dietary changes, or when the digestive tract is already inflamed.
The pattern can involve bile composition, cholesterol handling, bile-acid synthesis, intestinal reabsorption, or communication between the gut and liver.
ABCG8, CYP7A1, SULT2A1, KLB, SLC10A2
These genes represent different parts of cholesterol transport, bile-acid synthesis, bile signaling, metabolism, and intestinal recycling. They do not diagnose gallstones, gallbladder disease, liver disease, pancreatic disease, or bile-acid malabsorption.
Poor fat digestion or absorption can change how calcium and oxalate interact inside the intestine.
This may increase oxalate exposure in susceptible people and help explain why gut symptoms, poor fat tolerance, constipation, mineral sensitivity, and oxalate reactions sometimes appear together.
If your symptoms include burning, urinary irritation, mineral reactions, high-oxalate food sensitivity, or suspected enteric oxalate absorption, read the free oxalate DNA analysis.
Phosphatidylcholine production, sulfur metabolism, liver function, cellular membranes, and methylation demand can all influence bile-related biology.
If poor fat tolerance overlaps with choline sensitivity, methyl-donor reactions, sulfur pressure, or B-vitamin intolerance, read the free methylation DNA analysis.
This is a bile production, handling, or recycling problem, not simply an intolerance to dietary fat.
Persistent upper-right abdominal pain, jaundice, fever, vomiting, or pale stool requires medical evaluation rather than genetic interpretation alone.
The intestinal surface may have less reserve against disruption from microbes, inflammation, antibiotics, or infection.
The gut is protected by more than the intestinal cells themselves.
A mucus layer, secreted molecules, immune defenses, epithelial repair systems, and interactions with resident microbes help maintain separation between the intestinal contents and the tissues underneath.
Secretor biology can also influence which carbohydrate structures are displayed along mucosal surfaces. These structures may affect microbial attachment, ecological stability, and interactions between the host and microbiome.
When this surface-defense lane is more fragile, a person may recover less smoothly after the gut ecosystem is disrupted.
FUT2, ATG16L1, NOD2
These genes relate to different parts of secretor status, microbial sensing, cellular cleanup, intestinal defense, and host-microbe interaction. They do not prove that a person has “leaky gut,” dysbiosis, inflammatory bowel disease, or an intestinal infection.
Two people can carry similar organisms but interact with them differently.
The difference may involve mucus chemistry, secretor status, immune recognition, epithelial repair, intestinal movement, or the amount of fermentable material entering the colon.
This is why simply adding or eliminating bacteria does not always create lasting stability.
If the gut surface is already struggling to recover, repeated antimicrobial, probiotic, fasting, or restrictive-diet experiments can create additional change before the system has regained stability.
That does not mean every protocol is harmful. It means the sequence, intensity, and biological context may matter.
This is an intestinal interface and recovery problem, not simply a question of having good or bad bacteria.
The intestinal immune system may react more strongly and take longer to return to baseline.
The immune system inside the gut performs a difficult balancing act.
It must respond to infections and harmful organisms while tolerating food proteins, resident microbes, and other harmless exposures.
When immune tolerance is less stable, food or microbial triggers may create a stronger or more persistent response. Inflammatory symptoms may then resemble food intolerance even when the food itself is not the only issue.
HLA-DQA1, HLA-DQB1, IL2, IL21, JAK2, TNFSF15, IL23R
These genes may be relevant to antigen presentation, immune signaling, inflammatory regulation, and susceptibility patterns. They do not diagnose celiac disease, Crohn’s disease, ulcerative colitis, food allergy, or any autoimmune condition.
Certain HLA patterns are strongly associated with celiac susceptibility, but susceptibility is not the same as disease.
Many people carry a compatible HLA pattern and never develop celiac disease. Conversely, consumer microarray files may not provide complete or clinically validated HLA typing.
Clinical symptoms, antibody testing, medical history, and sometimes biopsy remain important.
An immune response can extend beyond the period when the food is physically present.
That can make it difficult to determine whether the current symptoms came from today’s meal, an exposure several days earlier, an infection, intestinal inflammation, or a broader immune flare.
This is an immune-threshold and recovery problem, not automatically a digestive-enzyme deficiency or simple intolerance.
Most people with chronic digestive reactivity try some combination of:
Sometimes these approaches are enough.
But they may plateau when the strategy does not match the active driver.
Adding fiber may not feel helpful when clearance is already severely delayed. Probiotics may not solve incomplete carbohydrate digestion. Digestive enzymes may not correct immune reactivity. Antimicrobials may create more instability when surface recovery is already fragile. Removing fat may reduce symptoms without explaining a bile-transport problem.
When the standard approach plateaus, the next question is usually not:
Which gut supplement should I add?
It is:
Which gut driver am I actually dealing with?
That is the gap Mutant is built to help organize.
Bloating, constipation, diarrhea, food sensitivity, and changing tolerance are outcomes.
They can develop through multiple routes:
This is why Mutant does not interpret one SNP as the cause of a complex gut-health pattern.
The goal is not to label someone as having “bad gut genes.”
The goal is to identify where inherited vulnerability may be clustering so that symptoms, testing, and next steps can be interpreted in a more organized way.
The phrase gut health DNA test can refer to two very different types of analysis.
A stool microbiome test analyzes genetic material from organisms present in a stool sample.
It may provide a snapshot of:
The microbiome can change with diet, medication, antibiotics, illness, travel, bowel transit, and many other exposures.
Mutant analyzes your inherited human DNA.
It asks whether your own biology may have vulnerabilities involving:
Your inherited DNA is relatively stable. It does not reveal the exact organisms currently living in your intestine.
A stool test asks:
What microbial patterns appear to be present in this sample?
Mutant asks:
How might my inherited biology shape digestion, clearance, barrier resilience, and response to microbial or food pressure?
Neither answer replaces the other.
Mutant is not a microbiome sequencing service, stool test, food-allergy test, or diagnostic laboratory.
Gut drivers rarely operate in isolation.
Thyroid signaling influences digestive movement, metabolic pace, tissue repair, bile handling, and bowel regularity.
When thyroid effect is low, food may move more slowly, fermentation may build, and constipation may amplify reactions that initially appear to be caused only by diet.
Read the free thyroid DNA analysis if digestive symptoms overlap with coldness, fatigue, weakness, low motivation, or thyroid-like symptoms despite normal TSH.
Stress can affect the digestive tract through autonomic signaling, muscle tension, visceral sensitivity, immune activation, and changes in motility.
A person may therefore experience genuine digestive changes during stress even when the trigger is not a new food.
The Stress, Mood & Neurochemical Regulation system helps organize the neurochemical and autonomic patterns that may amplify gut instability.
Slow clearance, intestinal inflammation, microbial metabolism, and weaker barrier resilience may all increase histamine-related pressure.
Read the free histamine DNA analysis if digestive symptoms overlap with flushing, itching, congestion, insomnia, food-triggered activation, chemical sensitivity, or mast-cell-like reactions.
Fat malabsorption, intestinal inflammation, altered calcium binding, slow transit, and barrier disruption can all change how oxalates behave inside the digestive tract.
Read the free oxalate DNA analysis if gut symptoms overlap with urinary irritation, burning, mineral sensitivity, joint discomfort, constipation, or reactions to high-oxalate foods.
Methylation, sulfur metabolism, choline biology, glutathione, redox balance, and B-vitamin handling may influence bile, cellular repair, inflammatory resilience, and tolerance for common gut protocols.
Read the free methylation DNA analysis if digestive symptoms overlap with reactions to methylfolate, B12, sulfur, choline, NAC, glutathione, or detoxification support.
Mutant analyzes gut-related genetic patterns across:
Mutant then combines the genetic pattern with questionnaire context.
This helps distinguish between a variant that is merely present and a biological lane that appears relevant to the person’s current symptoms.
The goal is not to diagnose a digestive disease.
The goal is to organize inherited gut-health vulnerability into a clearer driver map so users can see which processes may deserve attention first.
Mutant is currently offering free genetic pattern scans as part of our early product buildout.
The goal is simple:
We are being upfront about that.
The free scan is the starting point. The long-term product is a contextual AI companion that helps you understand what your patterns may mean over time.
Your raw DNA file is not the product.
The product is the interpretation layer we are building.
Mutant supports two levels of DNA input.
Starter analysis uses consumer microarray files such as 23andMe or AncestryDNA.
This can provide a useful first-pass view of common gut-related patterns.
Starter may help explore questions such as:
Consumer files do not measure every important variant. Coverage can be especially limited in complex immune regions such as HLA. A Mutant microarray result is not equivalent to clinical HLA typing, celiac testing, inflammatory bowel disease testing, or medical diagnosis.
Learn more about 23andMe raw data analysis
Learn more about AncestryDNA raw data analysis
WGS provides broader genomic coverage and fewer blind spots.
It may be a better fit when:
WGS still does not diagnose digestive disease or replace validated clinical testing.
The focus is not simply eating more fiber.
The more useful questions may include:
A motility-first pattern may require addressing movement and coordination before adding more fermentable material.
The focus is not eliminating every carbohydrate.
The questions become:
The goal is to identify the digestion bottleneck rather than treating all carbohydrates as equally problematic.
The focus is not automatically taking bile salts or avoiding all fat.
The questions become:
Because biliary symptoms can represent medical conditions, genetic interpretation should not replace proper testing.
The focus is resilience and recovery.
The questions become:
The goal is not to chase a perfect microbiome. It is to understand why the intestinal surface may be less resilient to change.
The focus is immune context rather than assuming every reaction is an intolerance.
The questions become:
Immune-risk genetics can help organize susceptibility, but they do not establish whether a disease is currently present.
Mutant is not a replacement for digestive testing.
Genetics helps organize inherited vulnerability. Testing helps show what may be happening now.
Depending on the symptom pattern, useful medical context may include:
The point is not to replace testing with DNA.
The point is that genetics and current-state testing answer different questions.
Testing asks:
What appears to be happening now?
Genetics asks:
Which gut systems may be more vulnerable under pressure?
Together, they can create a clearer picture.
Blood in the stool, black stool, jaundice, persistent vomiting, severe abdominal pain, unexplained weight loss, fever, anemia, dehydration, or a major unexplained change in bowel habits should receive medical evaluation.
If you have been trying to solve digestive symptoms through increasingly restrictive diets, random probiotics, repeated antimicrobials, or one-size-fits-all gut protocols, you may be missing the deeper question.
The real question is:
Which gut-health driver is most active in my biology?
Mutant organizes your raw DNA data and symptom context into a clearer gut driver map so you can stop treating every digestive reaction as the same problem.
A gut health DNA analysis examines inherited genetic patterns that may influence digestive movement, carbohydrate digestion, bile handling, mucosal defense, host-microbe interaction, and immune tolerance.
Mutant combines those patterns with symptom context to identify which gut-health drivers may be most relevant.
No.
A stool microbiome test analyzes microbial material found in a stool sample. Mutant analyzes your inherited human DNA.
Mutant cannot tell you exactly which bacteria are currently present in your intestine. Instead, it evaluates how your biology may influence digestion, clearance, barrier resilience, and response to food or microbial pressure.
Yes.
Mutant Starter analysis is designed to work with consumer raw DNA files such as 23andMe.
It may provide a first-pass view of common gut-related patterns, although coverage will vary by testing version and important variants may be missing.
Yes.
AncestryDNA raw data can be used for Starter analysis.
It may provide useful coverage of common variants, but it is still less complete than WGS.
WGS generally provides broader coverage and fewer blind spots.
That can matter when the pattern involves immune signaling, HLA-related regions, epithelial defense, bile transport, rare variants, or several interacting gut-health pathways.
WGS is still an educational genetic analysis and not a diagnostic gut-health test.
No.
IBS is diagnosed using medical history, symptom criteria, examination, and testing when needed to exclude other conditions.
Mutant may identify inherited patterns that could influence symptoms commonly associated with IBS, such as motility, fermentation, visceral stress response, and food-trigger sensitivity. It does not diagnose IBS.
No.
Mutant may identify genetic susceptibility patterns, but celiac disease requires appropriate clinical evaluation.
Having a compatible HLA pattern does not mean that a person has or will develop celiac disease. Consumer DNA files also may not provide complete clinical HLA typing.
No.
These patterns are common in the general population, while only a minority of carriers develop celiac disease.
Their greatest value is often in helping assess whether celiac disease is genetically plausible, not proving that it is present.
Usually not.
Genetics may identify pathways that affect the handling of particular food components, but symptoms still depend on dose, preparation, intestinal health, medications, microbiome activity, immune state, and other environmental factors.
Mutant is designed to identify drivers, not generate a permanent list of forbidden foods.
Fiber and probiotics can change fermentation, gas production, stool volume, and microbial activity.
If motility is slow, carbohydrate digestion is incomplete, or the intestinal surface is already unstable, adding more fermentable material or organisms may temporarily increase symptoms.
That reaction does not prove that all fiber or probiotics are harmful. It may indicate that the current intervention does not match the active driver, dose, or sequence.
Genes may influence parts of the intestinal environment, including mucus chemistry, immune recognition, digestion, and secretor biology.
However, the microbiome is also strongly shaped by food, medication, infections, environment, geography, age, and bowel transit.
DNA contributes to the environment in which the microbiome develops; it does not completely determine which organisms will be present.
No.
Mutant does not test IgE antibodies, diagnose food allergy, or predict anaphylaxis.
Suspected food allergy requires appropriate medical evaluation. Severe swelling, difficulty breathing, faintness, or rapidly progressing reactions require emergency care.
During the current founder-access period, Mutant is offering free genetic pattern scans to help users explore their biology and help improve the platform.
The long-term goal is a paid conversational AI subscription that helps users reason through their genetics, symptoms, labs, diet, and protocols in context.
No.
Mutant does not diagnose IBS, celiac disease, Crohn’s disease, ulcerative colitis, gallbladder disease, pancreatic disease, food allergy, infection, dysbiosis, or any other medical condition.
The Gut Health DNA Driver Map is an educational genetic pattern-analysis tool.
Important Note: Mutant provides educational, informational genetic pattern analysis. It does not diagnose, treat, cure, or prevent disease and is not a substitute for medical advice, diagnosis, or treatment.